XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Leases - Narrative (Details)
Sep. 30, 2024
USD ($)
ft²
Dec. 31, 2023
USD ($)
Sep. 30, 2023
Oct. 24, 2022
Nov. 15, 2021
ft²
renewalTerm
$ / ft²
Lessee, Lease, Description [Line Items]          
Rent increase         2.50%
Operating lease right-of-use assets $ 6,208,411 $ 6,674,394      
Weighted average remaining lease term 9 years 9 months 18 days   10 years 7 months 6 days    
Present value of remaining lease payments, percent 9.38%   9.40%    
Future minimum sublease income under noncancelable operating subleases $ 200,000        
Nephron Pharmaceuticals Corporation (“Nephron”)          
Lessee, Lease, Description [Line Items]          
Operating lease right-of-use assets $ 800,000        
Wet Laboratory and Office Space          
Lessee, Lease, Description [Line Items]          
Leased area | ft²         16,903
Term of contract         157 months
Base rent per square foot | $ / ft²         33.06
Lessee, Operating Lease, Remaining Lease Term       5 years  
Square feet of office space | ft² 14,200        
Wet Laboratory and Office Space | Broadwest Lease, Five Year Renewal Option          
Lessee, Lease, Description [Line Items]          
Number of renewal terms | renewalTerm         2
Renewal term         5 years